FDA to Launch Drug Supply Chain Security Act Regional Pilot Project
Blockchain technology will track intra- and inter- health care system medicine transfers.
ASHP Releases Compounded Sterile Prep Course
Self-guided, online program offers 36 hours of CE credits.
AbbVie’s Risankizumab-rzaa Granted Regulatory Approval
Indicated for adults with moderate to severe plaque psoriasis.
Walgreens to Implement New Tobacco Restrictions
The chain will now require customers to be 21 years of age to purcahse tobacco products.
Spravato for Treatment-Resistant Severe Depression (Update)
Esketamine comes with close supervision requirements. 800 clinics have already been approved and dispensed initial applications.
First Narcan Generic Gains Regulatory Approval
FDA granted final approval to drug originally tentatively approved in 2018.
Keytruda (Pembrolizumab) Issued New Dosage and Indication
The FDA has recently approved new dosage form and two new indications for the drug.
NHA Launches Learning Resource for Pharm Techs
Courses can be implemented alongside existing educational programs.
HHS Sec. Praises Community Pharmacies, Outlines Initiatives in NCPA Address
Reimbursement reform tops list of priorities, from DIR fees to rebates.
Soltamox (Tamoxifen Citrate) Issued Labeling Change
Women no longer require nine months of contraception post cessation of the drug.
DOVATO (Dolutegravir and Lamivudine) Approved for HIV-1
First-ever dual-drug, single tablet for HIV offers lighter treatment regimen.
Congressional Testimony Set for PBM CEOs
Advocates are calling for government regulations on PBMs and pharmacy.
Breast Cancer Drug Gains Approval for Males
America's Polypharmacy Predicament
New report highlights the dangers of prescription medications beyond opioids.
Wales Tests Antibiotic Prescriptions Handled by Pharmacists
"Test and treat" scheme reducing stress on general practitioners.
Hypertension Control Program May Go Nationwide
The program increased hypertension management rates to 77% in 2017.
ASHP Announces New VP of Government Relations
Tom Kraus to bring expeirence in government and industry.
Lucinda Maine Receives APhA Remington Honor Medal
Sunosi (Solriamfetol) Approved for Excessive Daytime Sleepiness in Adults
Solriamfetol is approved for adult patients suffering from the effects of narcolepsy and OSA.
15 Methods for Increasing Adoption of Pharmacist-Provided Care
New guide details actions for pharmacists and payers.
Mayzent (Siponimod) Granted FDA Approval for SPMS
The next-generation oral drug is the first to be approved specifically for secondary progressive multiple sclerosis in more than 15 years.
Bayer, J&J Pay $775 Million in Xarelto Lawsuits
More than 25,000 lawsuits cite uncontrollable and irreversible bleeding and death.
NACDS, NCPA, WSPA Join Forces to Support CMS Rule in Washington State
The groups say the state has intentionally suppressed dispensing fees to reimburse pharmacies that service Medicaid patients.
Zulresso Approved for Postpartum Depression in Adult Women
First drug approved for PPD use to remain under REMS program.
OTC Products Save U.S. Healthcare System Hours and Money
CHPA says over $146 billion and countless productivity hours are saved by the availability and accessibility of OTC medications and products.
Free Online Course Covering Pharmaceutical Controversies to be Offered by Harvard
The free course will cover a myraid of drug policy issues.
CMS Releases 2017 Drug Spending Dashboards
Aggregated data highlights manufacturers responsible for price increases.
OptumRx, UnitedHeathcare Expand Innovative Consumer Discounts
Beginning January 2020, all new employer clients must incorporate Point-of-Sale discounts.
FDA Approves Generic for Diovan
Ongoing valsartan shortages due to recalls prompt FDA prioritization.
Trazimera, Herceptin Biosimilar, Gains FDA Approval
Indicated for breast cancer, and gastric or gastroesophageal junction adenocarcinoma.